תרופן 27 מג
taro international ltd, israel - methylphenidate hydrochloride - טבליות עם שחרור נרחב - methylphenidate hydrochloride 27 mg - methylphenidate
תרופן 36 מג
taro international ltd, israel - methylphenidate hydrochloride - טבליות עם שחרור נרחב - methylphenidate hydrochloride 36 mg - methylphenidate
תרופן 54 מג
taro international ltd, israel - methylphenidate hydrochloride - טבליות עם שחרור נרחב - methylphenidate hydrochloride 54 mg - methylphenidate
לה בל אסתטיק-רדיאפן קרם להרגעת העור
נאוטק קבוצת קורדן בעמ - הרגעת העור
איקסל 25 מג
perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.
דולוקסטין די.אר. טבע 60 מג
teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 60 mg - duloxetine
דולוקסטין די.אר טבע 30 מג
teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 30 mg - duloxetine
יינטריב 20 מג
eli lilly israel ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 20 mg - duloxetine - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).
יינטריב 40 מג
eli lilly israel ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 40 mg - duloxetine - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).
סימבאלתה 30 מג
eli lilly israel ltd - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 30 mg - duloxetine - duloxetine - - cymbalta is indicated for the treatment of major depressive episodes. - cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain. this has been established is studies in patients with chronic low back pain and chronic pain due to osteoarthritis when other therapies have failed or are contra-indicated.